Perivesical inflammation and necrosis due to mitomycin c instillation after transurethral resection of bladder tumor: We must be Vigilant!

Urologia Internationalis

Volumn 83, Issue 3, 2009, Pages 362-363

  Fazlioglu, Adem ^a   Tandogdu, Zafer ^a,b   Kurtulus, Fatih Osman ^a   Parlakkilic, Oguzhan ^a   Cek, Mete ^a  

^a Taksim Teaching Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

Mitomycin C; Perivesical inflammation; Transurethral resection of bladder tumor

Indexed keywords

ANTIINFLAMMATORY AGENT; MITOMYCIN C;

AGED; ARTICLE; BLADDER PERFORATION; BLADDER TUMOR; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; HUMAN; IMAGE ANALYSIS; INFLAMMATION; MALE; NECROSIS; PELVIS PAIN SYNDROME; PERIVESICAL INFLAMMATION; PERIVESICAL NECROSIS; PRIORITY JOURNAL; SYMPTOM;

ADMINISTRATION, INTRAVESICAL; AGED; ANTI-BACTERIAL AGENTS; CYSTECTOMY; CYSTITIS; HUMANS; MALE; MITOMYCIN; NECROSIS; POSTOPERATIVE COMPLICATIONS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 70350345471     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000241684     Document Type: Article

References (9)

1. Racioppi M, Porreca A, Foschi N, Delicato G, Destito A, D'Addesi A: Bladder perforation: a potential risk of early endovesical chemotherapy with mitomycin C. Urol Int 2005; 75: 373-375.
2. Nieuwenhuijzen JA, Bex A, Horenblas S: Unusual complication after immediate postoperative intravesical mitomycin C instillation. Eur Urol 2003; 43: 711-712.
3. Oddens JR, van der Meijden APM, Sylvester R: One immediate postoperative instillation of chemotherapy in low risk TaT1 bladder cancer patients. Is it always safe? Eur Urol 2006; 46: 336-338.
4. Oosterlinck W, van der Meijden A, Sylvester R, Bohle A, Rintala E, Solsona Narvon E, Lobel B: Guidelines on TaT1 (non-muscle invasive) bladder cancer. European Association of Urology Guidelines, 2006, pp 1-17.
5. Yama N, Tsuchida Y, Nuka S, Kitagawa S, Saito J, Hyodoh H, Hyodoh K, Koito K, Tamakawa M, Akiba H, Hareyama M, Asai Y: Usefulness of magnetic resonance imaging for surgical management of extravasation of an antitumor agent: a case report. Jpn J Clin Oncol 2001; 31: 122-124.
6. Dohoerty AP, Trendell-Smith N, Stirling R, Rogers H, Bellringer J: Perivesical fat necrosis after adjuvant intravesical chemotherapy. BJU Int 1999; 83: 420-423.
7. Loth TS: Minimal surgical debridement for the treatment of chemotherapeutic agent induced skin extravasations. Cancer Treat Rep 1986; 70: 401-404.
8. Heitmann C, Durmus C, Ingianni G: Surgical management after doxorubicin and epirubicin extravasation. J Hand Surg 1998; 23: 666-668.
9. Tsavaris NB, Komitsopoulou P, Karagiaouris P, Loukatou P, Tzannou I, Mylonakis N, Kosmidis P: Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach. Cancer Chemother Pharmacol 1992; 30: 330-333.